POSC81 Cost-Effectiveness Analysis of Once-Daily Insulin Glargine 300 U/mL (Gla-300) vs Insulin Degludec (IDeg-100) Using the BRAVO Diabetes Model

Abstract

Authors

H Shao L Shi V Fonseca AJ Omar Alsaleh J Gill C Nicholls

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×